Polymorphisms of drug-metabolizing enzymes genes in a Han Chinese population

National Medical Journal of China

Volumn 89, Issue 38, 2009, Pages 2675-2681

  Liu, Liang ^a   Yang, Lin ^a   Zhang, Yan Chao ^a   Ai, Xiao Fei ^a   Wang, Jian Xiang ^a   Xiao, Zhi Jian ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Enzymes; Gene; Han nationality; Metabolic detoxication, drug; Polymorphism, genetic

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450 3A; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; NAT2 PROTEIN, HUMAN; NQO1 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ADOLESCENT; ADULT; ARTICLE; ASIAN; CAUCASIAN; CHILD; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ARYLAMINE N-ACETYLTRANSFERASE; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 CYP3A; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 84871459242     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.38.005     Document Type: Article

References (34)

1. Chowbay B, Zhou S, Lee EJ. An interethnic comparison of polymorphisms of the genes encoding drug ~ metabolizing enzymes and drug transporters: experience in Singapore. Drug Metab Rev, 2005, 37: 327-378.
2. Bolufer P, Collado M, Barragan E, et al. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Haematologica, 2007, 92: 308-314.
3. Zhou X, Barber WH, Moore CK, et al. Frequency distribution of cytochrome P450 3A4 gene polymorphism in ethnic populations and in transplant recipients. Res Commun Mol Pathol Pharmacol, 2006, 119: 89-104.
4. Voso MT, Fabiani E, D'Alo' F, et al. Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. Ann Oncol, 2007, 18: 1523-1528.
5. Hu YF, He J, Chen GL, et al. CYP3A5 z.ast; 3 and CYP3A4 z.ast; 18 single nucleotide polymorphisms in a Chinese population. Clinica Chimica Acta, 2005, 353: 187-192.
6. Park SY, Kang YS, Jeong MS, et al. Frequencies of CYP3A5 genotypes and haplotypes in a Korean population. J Clin Pharm Ther, 2008, 33: 61-65.
7. Niwa T, Shiraga T, Omura M, et al. Effect of genetic polymorphism of cytochrome P450 3 A and transporter gene on pharmacokinetics of tacrolimus, a calcineurin inhibitor. Nippon Yakurigaku Zasshi, 2006, 128: 395-404.
8. Liou YH, Lin CT, Wu YJ, et al. The high prevalence of the poor and ultrarapid metabolite alleles of CYP2D6, CYP2C9, CYP2C19, CYP3A4 and CYP3A5 in Taiwanese population. J Hum Genet, 2006, 51: 857-863.
9. Frere C, Cuisset T, Morange PE, et al. Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome. Am J Cardiol, 2008, 101: 1088-1093.
10. Bochud M, Eap CB, Elston RC, et al. Association of CYP3A5 genotypes with blood pressure and renal function in African families. J Hypertens, 2006, 24: 923-929.
11. Yang M, Choi Y, Hwangbo B, et al. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer, 2007, 57: 135-142.
12. Pope SK, Kritchevsky SB, Ambrosone C, et al. Myeloperoxidase polymorphism and cognitive decline in older adults in the Health, Aging, and Body Composition Study. Am J Epidemiol, 2006, 163: 1084-1090
13. Kang SH, Kim TY, Kim HY, et al. Association of NQO1 polymorphism with multiple myeloma risk in Koreans. Korean J Lab Med, 2006, 26: 71-76.
14. Wiencke JK, Spitz MR, McMillan A, et al. Lung cancer in Mexican-Americans and African ~ Americans is associated with the wild ~ type genotype of the NAD (P) H: quinone oxidoreductase polymorphism. Cancer Epidemiol Biomarkers Prev, 1997, 6: 87-92.
15. Katsuda N, Hamajima N, Tamakoshi A, et al. Helicobacter pylori seropositivity and the myeloperoxidase G463A polymorphism in combination with interleukin-1 B C-31T in Japanese health checkup examinees. Jpn J Clin Oncol, 2003, 33: 192-197.
16. Kiyohara C, Yoshimasu K, Takayama K, et al. NQO1, MPO and the risk of lung cancer: a HuGE review. Genet Med, 2005, 7: 463478.
17. Moon HW, Kim TY, Oh BR, et al. MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case-control study in Korea. Leuk Res, 2007, 31: 1213-1217.
18. Moon HW, Kim TY, Oh BR, et al. MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case-control study in Korea. Leuk Res, 2007, 31: 1213-1217.
19. Arai H, Yamamoto A, Matsuzawa Y, et al. Polymorphisms of apolipoprotein e and methylenetetrahydrofolate reductase in the Japanese population. J Atheroscler Thromb, 2007, 14: 167-171.
20. Gueant-Rodriguez RM, Gueant JL, Debard R, et al. Prevalence of methylenetetrahydrofolate reductase 677 T and 1298C alleles and folate status; a comparative study in Mexican, West African, and European populations. Am J Clin Nutr, 2006, 83: 701-707.
21. Oniki K, Hori M, Takata K, et al. Association between glutathione S-transferase A1, M1 and T1 polymorphisms and hypertension. Pharmacogenet Genomics, 2008, 18: 275-277.
22. Garte S, Gaspari L, Alexandrie AK, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev, 2001, 10: 1239-1248.
23. Soejima M, Sugiura T, Kawaguchi Y, et al. Association of the diplotype configuration at the N-acetyltransferase 2 gene with adverse events with co-trimoxazole in Japanese patients with systemic lupus erythematosus. Arthritis Res Ther, 2007, 9: R23.
24. Kukongviriyapan V, Prawan A, Tassaneyakul W, et al. Arylamine N-acetyltransferase-2 genotypes in the Thai population. Br J Clin Pharmacol, 2003, 55: 278-281.
25. Lu HF, Shih MC, Hsueh SC, et al. Molecular analysis of the thiopurine S-methyltransferase alleles in Bolivians and Tibetans. J Clin Pharm Ther, 2005, 30: 491-496.
26. Bolufer P, Collado M, Barragan E, et al. Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia. Br J Haematol, 2007, 136: 590-596.
27. Marvin LF, Delatour T, Tavazzi I, et al. Quantification of o, o'-dityrosine, o-nitrotyrosine, and o-tyrosine in cat urine samples by LC/electrospray ionization-MS/MS using isotope dilution. Anal Chem, 2003, 75: 261-267.
28. Kantarci OH, Lesnick TG, Yang P, et al. Myeloperoxidase-463 (G-A) polymorphism associated with lower risk of lung cancer. Mayo Clin Proc, 2002, 77: 17-22.
29. Costea I, Moghrabi A, Laverdiere C, et al. Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia. Haematologica, 2006, 91: 1113-1116.
30. Barragan E, Collado M, Cervera J, et al. The GST deletions and NQO1 z.ast; 2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemia. Leuk Res, 2007, 31: 947-953.
31. 2006, 45: 213-216.
32. Muller P, Asher N, Heled M, et al. Polymorphisms in transporter and phase II metabolism genes as potential modifiers of the predisposition to and treatment outcome of de novo acute myeloid leukemia in Israeli ethnic groups. Leuk Res, 2008, 32; 919-929.
33. Ansari M, Krajinovic M. Pharmacogenomics of acute leukemia. Pharmacogenomics, 2007, 8: 817-834.
34. Relling MV, Pui CH, Cheng C, et al. Thiopurine methyltransferase in acute lymphoblastic leukemia. Blood, 2006, 107: 843-844.